pBAD-P19-EGFP
(Plasmid
#196609)
-
PurposesiRNA vector expressing TMV P19 and a 720-long EGFP sequence as inverted repeat
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 196609 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGLO
-
Backbone manufacturerBio-Rad
- Backbone size w/o insert (bp) 4400
- Total vector size (bp) 6546
-
Modifications to backboneThe p19-T7_EGFPFL cassette was cloned from pGEX-4T-1-p19-T7-EGFPFL (Addgene #46310)
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)SURE
-
Growth instructionsInverted repeat is unstable. Check plasmid by restriction every time.
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namep19 + EGFP inverted repeat sequence
-
gRNA/shRNA sequenceGFP
-
SpeciesTomato bushy stunt virus
-
GenBank IDAJ288942
- Promoter AraC
-
Tags
/ Fusion Proteins
- 6x His tag (N terminal on insert)
- 6x His tag (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BglII (destroyed during cloning)
- 3′ cloning site PstI (not destroyed)
- 5′ sequencing primer tctctactgtttctccatacccg
- 3′ sequencing primer gcgtatcacgaggccctttc (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBAD-P19-EGFP was a gift from Franco Lucchini (Addgene plasmid # 196609 ; http://n2t.net/addgene:196609 ; RRID:Addgene_196609) -
For your References section:
siRNAs pools generated in Escherichia coli exhibit strong RNA-interference activity against influenza virus genomic sequences. Villa R, Renzi S, Dotti S, Lucchini F. Virology. 2022 Dec 31;579:38-45. doi: 10.1016/j.virol.2022.12.013. 10.1016/j.virol.2022.12.013 PubMed 36599198